MedPath
NMPA Approval

富马酸比索洛尔

国药准字H20057558

July 18, 2022

国药准字H20057558

Drug Information

富马酸比索洛尔

化学药品

July 18, 2022

Company Information

Applicant Company

Manufacturing Company

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.